Recent studies demonstrated that EPO administration increased AKT but not IRS phosphorylation to improve insulin resistance in 3T3L1 adipocytes16, 17 and to promote pancreatic β cell growth and survival11. The gene discussed is AKT1; the disease is Insulin resistance.